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EARLY LIFE EXPOSURE TO GENISTEIN AND DAIDZEIN DISRUPTS STRUCTURAL
DEVELOPMENT OF REPRODUCTIVE ORGANS IN FEMALE MICE
Jovana Kaludjerovic1, Jianmin Chen1, Wendy E. Ward1,2
1Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto,
Ontario, Canada5
2Department of Kinesiology, Center for Bone and Muscle Health, Faculty of Applied Health
Sciences, Brock University, St. Catharines, Ontario, Canada
In mice, exposure to isoflavones (ISO), abundant in soy infant formula, during the first 5 d
of life alters structural and functional development of reproductive organs. Effects of longer
exposures are unknown. The study objective was to evaluate whether exposure to a combina-
tion of daidzein and genistein in the first 10 compared to 5 d of life results in greater adverse
effects on ovarian and uterine structure in adult mice. Thirteen litters of 8–12 pups were
cross-fostered and randomized to corn oil or ISO (2 mg daidzein + 5 mg genistein/kg body
weight/d) for the first 5 or 10 d of life. The 10-d protocol mimicked the period when infants
are fed soy protein formula (SPF) but avoids the time when suckling pups can consume the
mother’s diet. Body and organ weights and histology of ovaries and uteri were analyzed. There
were no differences in the ovary or uterus weight, number of ovarian follicles, number of mul-
tiple oocyte follicles, or percent of ovarian cysts with 5 or 10 d of ISO intervention compared
to respective controls. The 10-d ISO group had higher body weights from 6 d to 4 mo. of age
and a higher percent of hyperplasia in the oviduct than the respective control. Lower numbers
of ovarian corpus lutea and a higher incidence of abnormal changes were reported in the uteri
of both ISO groups compared to their respective controls. Five- and 10-d exposure to ISO had
similar long-lasting adverse effects on the structures of ovaries and uterus in adult mice. Only
the 10-d ISO exposure resulted in greater body weight gain at adulthood.
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Foods, water, soil, cleaning reagents,25
plastics, and pharmacological agents can con-
tain estrogen-like compounds, referred to as
environmental estrogens, that imitate the nat-
ural activity of estrogen. Isoflavones (ISO), such
as daidzein, genistein, and glycitein, are a form30
of food estrogens that human infants fed soy
protein formula (SPF) consume at markedly
higher levels than infants fed breast milk or
cow’s milk based formula. Such levels may
have biological effects (Dinsdale and Ward35
2010; Reinwald and Weaver 2006). Although
exposure to ISO may induce biological effects
at any stage of the life cycle, the neonatal
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period is a particularly vulnerable stage of
life because endogenous estrogen production 40
is low, allowing ISO to more freely bind to
estrogen receptors (ERs) in estrogen-sensitive
tissues and thus to exert their maximal ER-
mediated effect (Reinwald and Weaver 2006).
Moreover, developing organisms are sensitive 45
to epigenetic programming (Barker 2002; Vieau
2011) and have an immature immune sys-
tem (Currie et al. 2011; Prescott et al. 2003),
poor liver metabolism (Lee et al. 2012), an
increased metabolic rate (Magos 2003), and 50
small body size, which are some of the rea-
sons why adverse effects occur in developing
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organisms at concentrations that are far below
the levels deemed harmful in adults (Bern
1992; Newbold et al. 2006). Consequently,55
questions have been raised regarding the safety
of ISO and the potential chronic adverse health
effects among adults who were exposed to SPF
during infancy (Dinsdale and Ward 2010), and
therefore long-term prospective trials evaluat-60
ing safety are ongoing (Gilchrist et al. 2004).
The sole retrospective cohort study of
young adults found no differences in pubertal
maturation, growth, or a wide range of repro-
ductive measures between those who were fed65
SPF and those who were fed cow’s milk for-
mula during infancy (Strom et al. 2001). The
only reported difference was that women fed
SPF had on average an 8-h longer duration
of menstrual bleeding and greater discomfort70
during menstruation compared to women fed
cow’s milk formula. No clinical studies eval-
uated the potential effects of SPF on ovarian
follicle development, but few studies exam-
ined the development of reproductive organs of75
infants fed SPF in the first few months or years
of life (Bernbaum et al. 2008; Gilchrist et al.
2010; Zung et al. 2008). One study reported no
marked difference in reproductive organ size,
as measured by ultrasound, between infants80
fed SPF, breast milk, or cow’s milk formula at
4 mo of age (Gilchrist et al. 2010). In contrast,
prospective studies of healthy infant fed breast
milk, cow’s milk or SPF showed that females fed
SPF display enhanced vaginal wall cell matura-85
tion at 6 mo of age (Bernbaum et al. 2008) and
more developed breast tissue at 2 yr of age than
infants fed breast milk or cow’s milk formula
(Zung et al. 2008). Thus, despite its long history
of use there is some concern that exposure to90
ISO present in SPF may exert adverse effects on
developing infants. In 2010, the U.S. National
Toxicology Program Center for the Evaluation
of Risks to Human Health Reproduction (NTP-
CERHR) concluded there was minimal concern95
(level 2) that SPF, containing ISO, produced
adverse reproductive and/or developmental
effects in exposed humans, but acknowledged
the paucity of well-designed clinical studies
to fully address concerns (McCarver et al.100
2011). In contrast, the European Society for
Paediatric Gastroenterology Hepatology and
Nutrition (ESPGHAN) has taken a more cau-
tious approach and is advising the public to
avoid the use of SPF, especially for infants less 105
than 6 mo of age, because of uncertainties
regarding safety in infants and young children
(Agostoni et al. 2006).
The CD-1 mouse model, a common animal
model for studying environmental estrogens, is 110
useful to predict effects in humans and explore
their mechanism of action (Jefferson et al.
2002; 2005; 2006a; 2006b; 2007a; 2007b;
2009; Newbold et al. 2001). To date, stud-
ies reported that short-term exposure (i.e., first 115
5 d of life) to genistein irreversibly disrupts
development by increasing the risk of obe-
sity, metabolic dysfunction, tumors including
uterine fibroids, ovarian and mammary-gland
cancer, and reproductive problems including 120
infertility/subfertility, endometriosis, and mul-
tiple oocyte follicles (MOF) several weeks or
months posttreatment (Dinsdale et al. 2011;
Jefferson et al. 2002; 2005; 2006; 2009;
Newbold et al. 2001). A recent study showed 125
that F1 females exposed to ISO for the first
10 or 21 d of life have reduced fertility by
55 and 60%, respectively, while fertility of
F2 females is not compromised (Dinsdale et al.
2011). In contrast, exposure to daidzein and 130
genistein during the first 5 d of life promotes
bone development and attenuate deteriora-
tion of bone tissue during aging by stimulating
bone calcification and bone matrix formation
(Kaludjerovic and Ward 2008; 2009; 2010; 135
Migliaccio 1996; Piekarz and Ward 2007).
Because timing of ISO exposure may mod-
ulate metabolic regulation and, in turn, the
risk of adult-onset diseases, it is important to
investigate how duration of exposure during 140
early life influences structural development of
reproductive organs, timing of puberty, sex-
ual behaviour, and fertility of sexually mature
animals. The objective of this study was to
determine how 5 versus 10 d of exposure 145
to a combination of daidzein and genistein—
the most abundant ISO present in SPF—
modulates weight and structural development
of ovaries and uterus of female CD-1 mice at
adulthood. 150
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METHODS
Animals and Treatment
Six-week-old CD-1 mice (n = 5 males,
n = 13 females) obtained from Charles River
Laboratories Canada (St. Constant, QC) were155
housed in the Department of Comparative
Medicine at the University of Toronto. Mice
were housed at 23◦C and 50% humidity on
a 12:12-h light–dark cycle, fed a semipuri-
fied diet (AIN93G) devoid of estrogenic com-160
pounds, and provided water ad libitum. After
2 wk of adaptation to the environment, mice
were mated harem style. Thirteen litters with
8–12 pups were cross-fostered and random-
ized to corn oil or ISO (2 mg daidzein/kg165
body weight/d + 5 mg genistein/kg body
weight/d) for the first 5 or 10 d of life. The
5-d protocol was selected to mimic previously
published studies investigating environmental
and dietary estrogens (Jefferson et al. 2002;170
2005; 2006b; 2007a; 2009; Newbold et al.
2001), and the 10-d protocol was chosen to
more closely represent the period in which
human infants fed SPF may be exposed to
ISO but avoiding the time when suckling pups175
may start to consume mother’s diet. Purified
daidzein and genistein powder, purchased from
Sigma-Aldrich (Mississauga, ON), was solubi-
lized in 1 ml dimethyl sulfoxide (DMSO) and
suspended in corn oil (Kaludjerovic and Ward180
2009). Each morning, treatments were admin-
istered via subcutaneous injection using a total
volume of 20 μl/pup/d. Kaludjerovic et al.
(2011) previously showed that subcutaneous
(sc) delivery versus oral feeding, and daily ver-185
sus multiple oral doses, do not result in signifi-
cantly different levels of total serum daidzein,
genistein, equol and O-DMA in the devel-
oping CD-1 mice. However, oral feeding in
the first week of life is difficult because of190
the pup small body size. Oral feeding also
results in higher variability of serum ISO con-
centrations, marked stress and a higher risk
of death due to aspiration or perforation of
tissues than administering isoflavones by sc195
injection (Kaludjerovic et al. 2011). The admin-
istered dose results in serum ISO levels that
are similar to those of human infants fed SPF
(Kaludjerovic and Ward 2009; Kaludjerovic
et al. 2011). On postnatal day (PND) 21, 200
mice were weaned, and thereafter only female
mice were studied because our previous find-
ings showed that female mice have a greater
response to ISO exposure (Kaludjerovic and
Ward 2009; 2010). Body weight of mice was 205
measured daily from birth to PND 10, at wean-
ing (PND 21), and every 4 wk thereafter until
PND 120, representing young adulthood (Ward
et al. 2007). Necropsy occurred at 4 mo of age,
at which time organs were collected and stage 210
of estrous cycle was not established. Organ
weight was used to monitor for gross adverse
effects due to ISO. All procedures involving live
animals were reviewed and approved by the
University of Toronto Animal Care Committee 215
and compliant with the Canadian Council on
Animal Care (Canadian Council on Animal Care
1993).
Histology
Ovaries and uteri were excised and fixed in 220
10% buffered formalin. Samples were embed-
ded in paraffin and sectioned using the method
developed by Jefferson et al. (2009) and
Newbold et al. (2009) such that 18 sections per
mouse were analyzed with a maximum interval 225
of 450 μm. Tissue sections were stained with
hematoxylin and eosin (H&E) and evaluated by
light microscopy. Both uterine horns were cut
1 mm from the uterine body. The cervix (10-d
treatment only) was obtained from the caudal 230
portion of uterine body. Six serial sections (each
at an interval of 100 μm) were evaluated for
each mouse. The ovary, oviduct, uterus, and
cervix were analyzed by a blinded observer
(J. C.) to determine the presence of abnormal- 235
ities. Secondary follicle is defined as pre-antral
follicle that represents theca cells, multiple lay-
ers of granulosa cells, and the zona pellucid,
while tertiary follicle is defined as antral follicle
that contains antrum (fluid-filled cavity) (Amleh 240
and Dean 2002; Arango and Donahoe 2008).
Statistics
The numbers of follicles (secondary to ter-
tiary follicles) and corpus lutea (CL) per mouse
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are presented as mean ± standard error of245
mean. All other data are presented as a pro-
portion of mice within the group having the
abnormality. Student’s t-test was used to com-
pare litter size, body weight, and uterine and
ovarian weights, as well as the number of250
follicles between the control and ISO treatment
group for the 5- and 10-d interventions, respec-
tively. All other frequencies were evaluated by
chi-squared (Fisher exact) test. All analyses were
performed using Sigma Stat. Statistically sig-255
nificant differences were defined as p < .05.
RESULTS
Litter Size, Body Weight, and Relative
Organ Weight260
There were no differences in litter size and
birth weight among the respective control and
ISO groups (data not shown). Body weight
from birth to 4 mo of age was not significantly
different between the 5-d ISO group and its265
respective control (Figure 1). In contrast, 10-d
treated females had significantly higher body
weight from PND 6 to 4 mo of age compared
to its respective control group (Figure 1). The
5- or 10-d ISO exposure had no effect on the270
weight of ovaries, uteri, kidneys, and liver when
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FIGURE 1. Body weight from weaning to 4 mo. of age of mice
treated for the first 5 or 10 d of life with corn oil or ISO: ◦ denotes
5 d corn ISO group; • denotes 5 d corn oil group;  denotes
10 d ISO group;  denotes 10 d corn oil group; asterisk indicates
significant difference, 10-d ISO group > 10-d corn oil group,
p < .05.
expressed as percent body weight (Table 1).
Absolute liver weight of 5- and 10-d treated ISO
groups was significantly higher than that of its
respective control group, with no differences in 275
absolute weight of other organs with either 5 or
10 d of ISO exposure (Table 1).
Ovary and Oviduct
There was no significant difference in the
number of follicles, from secondary to preovu- 280
latory follicles, between the respective control
and ISO groups (Table 2). The number of CL
was significantly lower in the ISO groups com-
pared to their respective controls, of which
5 mice in the 5-d ISO (41.7%) and one 285
mouse in the 10-d ISO (7.7%) groups had no
CL (Table 2; Figure 2A). Ovaries without CL
were filled with interstitial cells in the stroma
(Figure 2A). Three mice from the 5-d ISO
(25.0%) and one from the 10-d ISO (7.7%) 290
group showed abnormal cyst-like structure in
the ovaries (Figure 2B). One mouse from each
10-d group, CON and ISO, had one MOF
(Table 2; Figure 2C). ISO treatment induced
hyperplasia, with mucosal folds extending to 295
serosa, in the oviduct of 3 out of 12 (25.0%)
and 5 out of 13 (38.5%) mice in the 5- and 10-d
ISO groups, respectively (Table 2; Figure 2D).
Uterus and Cervix
A significantly higher frequency of abnor- 300
mal changes was observed in the ISO groups,
7 out of 12 (58.3%) and 8 out of 13 (69.2%)
in the 5- and 10-d ISO groups, respectively
(Table 2). There were two types of alter-
ations observed in the uterus: endometrial 305
hyperplasia and edema in the stroma.
Hyperplasia was the major histological
change in the mice treated with ISO and
only one mouse in the 10-d control group
had hyperplasia (Table 2). Hyperplasia with 310
endometrial gland complex, consisting of
multiple glands or glandular crowding with
glands interconnecting (Figure 3A and 3B),
was observed only in the ISO-treated mice.
Moreover, 3 out of 12 (25.0%) and 2 out of 315
13 (14.4%) mice from the 5- and 10-d ISO
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TABLE 1. Organ Weights From 4-mo-Old Female Mice Expressed Both as Percent of Body Weight and as Absolute
5 d CON 5 d ISO 10 d CON 10 d ISO
Organ weight expressed as percent of body weight
Ovaries 0.0513± 0.0036 0.0543± 0.0038 0.0589± 0.00396 0.117± 0.0335
Uterus 0.3966± 0.0527 0.4373± 0.0503 0.413± 0.0382 0.357± 0.0449
Kidney 1.055± 0.0412 1.028± 0.0439 1.148± 0.125 1.109± 0.0703
Liver 4.080± 0.113 3.759± 0.134 4.425± 0.206 4.636± 0.153
Absolute organ weight
Ovaries 0.0191± 0.0016 0.0206± 0.0016 0.0220± 0.00131 0.0485± 0.0143
Uterus 0.139± 0.0140 0.163± 0.0187 0.153± 0.0119 0.151± 0.0187
Kidney 0.390± 0.0208 0.387± 0.0161 0.430± 0.0442 0.454± 0.0270
Liver 1.56± 0.139 1.45± 0.0947 1.729± 0.154b 1.947± 0.107a
Note. Data are presented as mean ± standard error of mean. Different superscripts in a row denote significant differences among
groups, p ≤ .05.
TABLE 2. Histological Abnormalities of Ovaries, Oviducts, Uteri, and Cervix of CD-1 mice at 4 mo of Age
5 d CON 5 d ISO 10 d CON 10 d ISO
Ovary
Follicles, n/ovary 9.9 ± 1.1 10 ± 1.1 13 ± 1.4 11 ± 1.3
Corpus luteum (CL), n/ovary 9.1 ± 1.2a 4.3 ± 1.7b 11 ± 1.3a 5.1 ± 0.68b
Absence of CL, n/n total (%) 0/11 (0)a 5/12 (41.7)b 0/12 (0) 1/13 (8)
Cysts, n/n total (%) 0/11 (0) 3/12 (25.0) 0/12 (0) 1/13 (8)
MOF, n/n total (%) 0/11 (0) 0/12 (0) 1/12 (8) 1/13 (8)
Oviduct
Hyperplasia, n/n total (%) 0/11 (0) 3/12 (25) 0/12 (0)a 5/13 (39)b
Uterus
Abnormal, n/n total (%) 0/11 (0)a 7/12 (58)b 1/12 (8)a 8/13 (69)b
Hyperplasia, n/n total (%) 0/11 (0)a 6/12 (50)b 1/12 (8) 5/13 (39)
Atypia, n/n total (%) 0/11 (0) 3/12 (25) 0/12 (0) 2/13 (15)
Polyps, n/n total (%) 0/11 (0) 1/12 (8) 0/12 (0) 1/13 (8)
Cyst, n/n total (%) 0/11 (0) 2/12 (17) 0/12 (0) 1/13 (8)
Edema, n/n total (%) 0/11 (0) 1/12 (8) 0/12 (0) 4/13 (31)
Cervix
Microglandular structures, n/n total (%) Not tested Not tested 0/12 (0) 4/13 (31)
Note. Data are presented as mean ± standard error of mean or the proportion of mice within the group having abnormality. Different
superscripts in a row denote significant differences among groups, p ≤ .05. Numbers in parentheses represent the percent of mice, out of
the total number of mice studied, for which the effect was observed. Abbreviations: control, CON; corpus luteum, CL; multiple oocyte
follicle, MOF; soy isoflavones, ISO.
groups, respectively, showed hyperplasia with
atypia. One mouse from each ISO group
developed endometrial polyps, abnormal
projections of endometrium into lumen (8.3%320
and 7.7%, for 5- and 10-d groups, respectively)
(Figure 3A). In addition, cystic hyperplasia
was also presented in the ISO groups with
2 out of 12 (16.7%) and 1 out of 13 (7.7%) for
5- and 10-d ISO groups, respectively (Table 2;325
Figure 3B). Endometrial edema existed in the
ISO groups with 1 out of 12 (8.3%) and 4 out
of 13 (30.8%) for 5- and 10-d ISO groups,
respectively (Table 2; Figure 3C). In the cervix,
the microglandular structures in the epithelium330
were observed in mice treated with 10 d of
exposure to ISO at incidence 4 out of 13
(30.8%) (Table 2; Figure 3D).
DISCUSSION
This is the first study to show that 5 and 335
10 d of exposure to ISO exerted similar adverse
effects on structural development of ovaries
and uteri in sexually mature female mice. Both
5 and 10 d of ISO exposure resulted in a
lower number of ovarian CL and a higher inci- 340
dence of oviduct hyperplasia, as well as a higher
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FIGURE 2. Representative microphotographs of ovary and oviduct from 4-mo-old mice treated with ISO. (A) Stroma of ovary that lacks
corpus luteum is filled with interstitial cells (IC). Note a big atrophic cyst-like follicle (F) (5 d); H&E, 100×. (B) A big cyst (C) with
degenerating cells in the ovary; corpus luteum (CL) (5 d); H&E, 100×. (C) A multiple oocyte follicle with two oocytes (O) (10 d); H&E,
400×. (D) Hyperplastic mucosal folds in the oviduct have extended to the serosa (arrow) (10 d); H&E, 400×.
occurrence of hyperplasia, atypia, polyps, and
cysts in the uterine tissue structure. These find-
ings are comparable to changes observed in
mice with neonatal exposure to potent environ-345
mental estrogens such as DES and bisphenol A
and thus support the hypothesis that ISO bind
to ER to induce estrogen-like effects in repro-
ductive tissue (Adewale et al. 2009; Newbold
et al. 2001; 2007). It is well documented that350
the unique biological response of a tissue to ISO
involves three interrelated factors, including the
type and level of ERα and ERβ expression, the
nature of conformational change that occurs
in the ER upon ligand binding, and the type355
and expression level of co-regulatory proteins
(Riggs and Hartmann 2003). Both ERα and
ERβ are expressed in the female reproductive
tissue during pregnancy (Couse et al. 1997;
Jefferson et al. 2000; 2007b; Sar and Welsch 360
1999). In late gestation and early postnatal life,
ERα is localized to the stromal and epithe-
lial cells of the uterus and the interstitium of
the ovary, while ERβ is limited to the ovar-
ian granulosa cells with minimal expression in 365
the uterus (Jefferson et al. 2000; 2007b; Sar
and Welsch 1999; Yamashita et al. 1990). How
this distribution of ERα and ERβ expression
affects reproductive function is currently not
well understood, but it is generally accepted 370
that changes in ER expression might alter hor-
mone production, nongenomic signaling, and
the transcription of various genes including
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FIGURE 3. Representative microphotographs of uterus and cervix from 4-mo-old mice treated with ISO. (A) Uterine structure from a
10-d-old corn oil-treated mouse, uterine lumen (L), endometrium (E) myometrium (M); H& E. (B) Polyp (P) with hyperplastic glands (∗);
uterine lumen (L) (5 d); H&E, 100×. (C) Cystic (C) and hyperplastic glands in the uterus (∗); uterine lumen (L); myometrium (M) (5 d);
H&E, 50×. (D). Edema in the endometrium (E) from a 10 d treated mouse; myometrium (M); H&E, 100×. (E). Cervix from a 10-d-old
corn oil treated mouse; lumen (L) H&E 100×. (F) Microglandular structures (arrow) in the cervix; lumen (L) (10 d); H&E, 100×.
steroid receptors, enzymes, and transcription
factors. These changes have the potential to375
be inherited during cell division, resulting in
permanent maintenance of the acquired phe-
notype (Day et al. 2002; Sato et al. 2009).
In one study, rat pups whose lactating moth-
ers were treated with ISO (100–200 mg/kg380
body weight/d) from PND 5 to 10 had higher
expression of ERβ on PND 11 in the ovaries
but lower expression in the uterus when com-
pared to the control group (Liu et al. 2008).
In a different study, continuous exposure to385
genistein, beginning prenatally to 21 or 97 d of
life, resulted in lower mRNA expression of ERα,
ERβ, complement component 3 (C3), clusterin
(Clu), insulin-like growth factor-1 (IGF-1), and
IGF-1 receptor (IGF-1R) in the uterine tissue 390
of juvenile mice (Moller et al. 2009). In utero
exposure to genistein and daidzein, respec-
tively, was also shown to induce hypermethy-
lation of the transposable repetitive elements
upstream of the transcription start site (Dolinoy 395
et al. 2006) and to reduce expression of ERα
in the brain of female mice (Yu et al. 2010),
suggesting that ISO may exert profound effects
on long-term programming of health. To bet-
ter understand how ISO modulate reproduc- 400
tive health, further information on aberrant
DNA methylation and gene expression includ-
ing high-throughput analysis is required.
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Mouse studies investigating the effects of
environmental estrogens on programming of405
reproductive health have typically introduced
the intervention in the first 5 d of life because
this is the period when endogenous con-
centrations of sex steroid hormones are low
(Cimafranca et al. 2010; Jefferson et al. 2002;410
2005; 2006a; 2006b; 2007a; 2007b; 2009).
However, mice suckle for the first 21 d of life,
which is the time when human infants consume
SPF, but reach sexual maturation shortly after
the end of suckling. This makes it difficult to415
identify the most appropriate duration of expo-
sure to mimic human infants fed SPF. A 10-d
protocol was used in this study to more closely
mimic the period when human infants are fed
SPF while avoiding the time when suckling pups420
may start to consume maternal diet.
Overall, findings from this study indicate
that the induction of numerous abnormalities
in the ovaries and uteri of adult female mice is
not significantly different between the 5- and425
the 10-d exposure to ISO. In agreement with
this evidence, Dinsdale et al. (2011) recently
showed that mice exposed to the same dose of
ISO (7 mg/kg body weight/d) used in this study
for the first 10 or 21 d of life display comparable430
disruptions in ovarian folliculogenesis, uterine
hyperplasia and atypia at 4 mo of age. Taken
together, these studies suggest that the first 5 d
of life represents a critical window of develop-
ing during which ISO can program reproductive435
health.
Jefferson et al. previously showed that
CD-1 mice exposed to low doses of genistein
(0.5 and 5 mg/kg /d) from PND 1 to 5 have
an increased number of ovarian CL, while440
those exposed to high doses of genistein
(50 mg/kg/d) have reduced number of ovarian
CL at 4 mo of age (Jefferson et al. 2006b). In a
separate study, C57BL mice exposed orally to
a mixture of genistein (50 mg/kg/d), soy pro-445
tein formula, and corn oil from PND1 to 5 had
increased uterine weight and incidence of MOF
in the ovaries on PND 5, but had normal fertility
at 6 mo of age (Cimafranca et al. 2010). Based
on these findings, Cimafranca et al. (2010)450
raised concern that genistein may exert adverse
effects on reproductive development of human
infants fed soy protein formula. However, the
effects induced by genistein may be different
from those induced by an ISO mixture. This 455
study and another study from our laboratory
showed that when genistein is administered in
combination with daidzein for the first 5, 10,
or 21 d of life, female mice have a reduced
number of ovarian CL at 4 mo of age (Dinsdale 460
et al. 2011). Fewer CL indicate that ovulation
is reduced. Whether these effects are due to
daidzein per se or to its ability to attenuate
the effect of genistein on the hypothalamic–
pituitary–gonadal axis has not been elucidated. 465
One study showed that rats treated with 17β-
estradiol or genistein for the first 5 d of life
have a lower lordosis quotient at 2 mo of
age, while those treated with daidzein have
a higher lordosis quotient compared to the 470
control group (Kouki et al. 2003). Lordosis quo-
tient is a measure of sexual behaviour, and
based on these findings it may be concluded
that genistein and daidzein exert divergent
effects on sexual differentiation of the brain 475
and sexual behavior. Exposure to 17β-estradiol
or genistein during neonatal development may
increase responsiveness to estradiol in adult-
hood, while daidzein exposure may reduce
responsiveness. Thus, genistein and daidzein 480
may be inducing biological effects through dif-
ferent mechanisms.
Studies demonstrated that exposure to
7 mg of ISO/kg body weight for the first 5 d
of life results in higher body weight at 28 wk 485
of age (Kaludjerovic and Ward 2010) but not at
early stages of development (Cimafranca et al.
2010; Kaludjerovic and Ward 2009). However,
this increase in body weight might be observed
sooner if pups are exposed to higher doses 490
of ISO in the first 5 d of life (Newbold et al.
2005), or if treatment is extended to first 10 or
21 d of life (Dinsdale et al. 2011). In this study,
differences in body weight appeared on PND
6 and persisted to 4 mo of age when female 495
mice were exposed to ISO from PND1 to 10.
Thus, while duration of ISO exposure affected
body weight differently in this study, 5- and 10-
d exposure to ISO did not result in marked
differences in the number of histological abnor- 500
malities in the ovaries or uteri, indicating that
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different tissues respond differently to ISO. The
mechanism by which 10 d of exposure to ISO
increases body weight but has no additional
adverse effects on reproductive health remains505
to be elucidated.
This study is unique in that it compares
the 5- and 10-d exposures to better char-
acterize the critical window of development
during which ISO program reproductive health510
in CD-1 mice. It is generally accepted that no
animal model exactly represents the human
infant, but nonetheless might provide a use-
ful basis for human studies (Dinsdale and Ward
2010; Klein et al. 2010; Reinwald and Weaver515
2006). In conclusion, 5-d exposure represents
a sensitive window of development during
which exposure to ISO can alter structural
development of ovaries and uteri in rodents
and may therefore be a factor in precocious520
human development. These findings raise con-
cern that exposure to ISO during postnatal life
may increase the risk of disrupting the structural
development of reproductive organs. Findings
from prospective studies of infants fed SPF,525
cow’s milk formula, and breast milk, some of
which are ongoing, are needed to address the
paucity of data regarding the safety of ISO
on structural and functional development of
reproductive organs in adults.530
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